Table.

Historical Milestones of the Texas Heart Institute (1962–1999)

1962
 • Texas Heart Institute founded by Denton A. Cooley, MD
1968
 • First successful heart transplantation in the United States
1969
 • First implantation of a total artificial heart in a human
1974
 • First issue of the Texas Heart Institute Journal is published, under the name Cardiovascular Diseases: Bulletin of the Texas Heart Institute
1975
 • First study funded by the National Heart, Lung, and Blood Institute of an implantable LVAD for postcardiotomy support
1976
 • First accredited School of Perfusion Technology in the United States
1978
 • First use of an LVAD as a bridge to transplantation
1981
 • Second implantation of a total artificial heart in a human
1985
 • First laser angioplasty procedure in the United States
 • First laser coronary endarterectomy procedure in the United States
1986
 • First peripheral laser procedure in Texas (one of the first such procedures in the United States)
 • First implantation of the HeartMate pneumatically powered LVAD as a bridge to transplantation
1990
 • First cases of Maze surgery performed at SLEH for atrial fibrillation
1991
 • First patient ever to leave the hospital with an electric, portable, battery-powered LVAD
1993
 • THI selected as one of 7 centers in the United States to participate in the federal government’s Heart Demonstration Project for Medicare patients
 • American Heart Association journal Circulation placed at THI/SLEH for an 11-y period, the second longest tenure of placement in the journal’s history, with Dr James Willerson as Editor-in-Chief
1994
 • FDA approval to use the HeartMate pneumatic LVAD as a bridge to transplantation
1996
 • FDA approval to use the electric HeartMate as a bridge to transplantation
1998
 • One of 6 centers chosen for cardiac magnetic resonance imaging trials
 • Groundbreaking for the new THI/SLEH—The Denton A. Cooley Building
1999
 • FDA approval of a stent graft tested exclusively at THI/SLEH for repair of abdominal aortic aneurysm
  • FDA indicates Food and Drug Administration; LVAD, left ventricular assist device; SLEH, St. Luke’s Episcopal Hospital; and THI, Texas Heart Institute.